「ACETYLCHOLINE」の共起表現一覧(1語右で並び替え)
該当件数 : 176件
hrocyte cholinesterase, or (most formally) | acetylcholine acetylhydrolase, found primarily in the bl |
cholinesterase functions to deactivate the | acetylcholine almost immediately by breaking it down. |
ich has a short action time, is similar to | acetylcholine and acts as a partial agonist of the nicot |
It also increases release of | acetylcholine and noradrenaline, and improves memory ret |
They are stimulated by muscarine and | acetylcholine, and blocked by atropine. |
The structure of the binding site for the | acetylcholine and nicotine was located at the interface |
hances the potassium-stimulated release of | acetylcholine and glutamate. |
rtant central neurotransmitters, including | acetylcholine and glutamate have been reported. |
nzyme choline acetyltransferase to produce | acetylcholine and a coenzyme a byproduct. |
his work on neuromodulators, particularly | acetylcholine, and for his computational modelling work |
e symptoms of schizophrenia, and increases | acetylcholine and glutamate levels in the prefrontal cor |
ns that release the transmitter substances | acetylcholine and serotonin. |
ts primarily as a selective α3β4 nicotinic | acetylcholine antagonist, and is even more selective tha |
It is therefore classified as an indirect | acetylcholine antagonist. |
o found to act as selective α3β4 nicotinic | acetylcholine antagonists, with little or no effect on N |
acetylcholine antagonists. | |
A receptor is cholinergic if it uses | acetylcholine as its neurotransmitter. |
For his study of | acetylcholine as agent in the chemical transmission of n |
erase by phosphorylation, so the action of | acetylcholine becomes prolonged, pralidoxime (2-PAM) is |
known as muscarinic receptor antagonists - | acetylcholine being the neurotransmitter of the parasymp |
Unlike | acetylcholine, bethanechol is not hydrolyzed by cholines |
N) to respond to a neurotransmitter called | acetylcholine; BFCN are important for the processes of l |
After | acetylcholine binding, the receptor undergoes an extensi |
With the enzyme inhibited, | acetylcholine builds up in the synapse and continues to |
All three ACh-inhibiting ( | Acetylcholine) chemicals can be found in the leaves, ste |
AChE is an enzyme that removes | acetylcholine from the synapse after it creates the requ |
g further effects to the normal release of | acetylcholine from the presynaptic terminal, and therefo |
annel superfamily is composed of nicotinic | acetylcholine, GABAA, GABAA-ρ, glycine and 5-HT3 recepto |
the rate limiting step in the synthesis of | acetylcholine; hence, hemicholinium-3 decreases the synt |
ssible neurotransmitter substances such as | acetylcholine, histamine, substance P, and serotonin. |
Acetylcholine hyperpolarizes the sinoatrial node which i | |
Intake of | acetylcholine in axoplasm is prevented and the presynapt |
inhibitor which prevents the breakdown of | acetylcholine in the synapse. |
, the acetylcholinesterase breaks down the | acetylcholine in the synaptic cleft in order to allow th |
nsmission by interfering with synthesis of | acetylcholine in nerve endings. |
rgic drug designed to reduce the levels of | acetylcholine in the treatment of Parkinson's disease. |
It stimulates release of dopamine and | acetylcholine in the brain in both rodent and primate mo |
AMPA-mediated release of noradrenaline and | acetylcholine in the hippocampus and frontal cortex of t |
r asystole during Stokes-Adams attacks and | acetylcholine injections. |
nism of breaking down the neurotransmitter | acetylcholine into its constituents, acetate and choline |
yze the hydrolysis of the neurotransmitter | acetylcholine into choline and acetic acid, a reaction n |
Acetylcholine is synthesized from choline and a donated | |
Acetylcholine is associated with attention, concentratio | |
If it gets inhibited, | acetylcholine is not removed after the stimulation and m |
Once this receptor binds | acetylcholine, it undergoes an extensive change in confo |
ed in animals, and found to increase brain | acetylcholine levels and produce nootropic effects, as w |
nown to be a partial agonist of muscarinic | acetylcholine M1, M2 , M3 receptors and M4, which is bel |
act as inhibitors of the neurotransmitter | acetylcholine, may provide some relief. |
testinal tract by blocking the activity of | acetylcholine on cholinergic (or muscarinic) receptors o |
by antagonism of the excitatory effects of | acetylcholine on the cortex, reduction of locomotor acti |
inity for adrenaline, dopamine, muscarinic | acetylcholine, or serotonin receptors, or any of the mon |
turnover number was 3 x 107 (molecules of | acetylcholine) per minute per molecule of enzyme. |
erase hence increases the concentration of | acetylcholine present). |
le to a neuron will decrease the amount of | acetylcholine produced. |
th the nootropic effect from the increased | acetylcholine production cancelled out by the opposite e |
acetyltransferase, resulting in increased | acetylcholine production. |
It is a nicotinic | acetylcholine receptor antagonist. |
Aceclidine acts as a muscarinic | acetylcholine receptor agonist. |
also mildly anticholinergic, or muscarinic | acetylcholine receptor antagonistic. |
It also acts as a nicotinic | acetylcholine receptor antagonist. |
CHRNA7, coding the neuronal nicotinic | acetylcholine receptor alpha7 subunit. |
ts mode of action is through the nicotinic | acetylcholine receptor where it acts as an analogue of a |
An | acetylcholine receptor (abbreviated AChR) is an integral |
The | acetylcholine receptor changes conformation upon acetylc |
by this gene is a subunit of the nicotinic | acetylcholine receptor (nAchR). |
ylphenylpiperazinium (DMPP) is a nicotinic | acetylcholine receptor agonist which is selective for th |
nt, noncompetitive α3β4 neuronal nicotinic | acetylcholine receptor antagonist. |
Acetylcholine receptor subunit delta is a protein that i | |
racetam family, and an antidepressant (M1 | acetylcholine receptor agonist). |
Acetylcholine receptor subunit beta is a protein that in | |
ism of action is to bind to the muscarinic | acetylcholine receptor M1. |
Neuronal | acetylcholine receptor subunit alpha-7 is a protein that |
Cytisine is a nicotinic | acetylcholine receptor agonist, and as a pharmaceutical |
Structure of the nicotinic | acetylcholine receptor (nAchR: PDB 2BG9) which is very s |
Neuronal | acetylcholine receptor subunit alpha-2 is a protein that |
Neuronal | acetylcholine receptor subunit alpha-3 is a protein that |
Neuronal | acetylcholine receptor subunit alpha-9 is a protein that |
d-gated ionic channel family and nicotinic | acetylcholine receptor gene superfamily. |
Neuronal | acetylcholine receptor subunit beta-3 is a protein that |
Neuronal | acetylcholine receptor subunit alpha-10 also known as ch |
lly moderately to highly potent muscarinic | acetylcholine receptor (anticholinergic) antagonists as |
onist, with specificity for the Muscarinic | acetylcholine receptor M2, made it a promising starting |
uscle, where it may regulate agrin-induced | acetylcholine receptor clustering at the neuromuscular j |
inds irreversibly and competitively to the | acetylcholine receptor found at the neuromuscular juncti |
a selective antagonist of the α7 nicotinic | acetylcholine receptor in the brain, and as such has app |
The | acetylcholine receptor of muscle has 5 subunits of 4 dif |
its antihistamine effects, and muscarinic | acetylcholine receptor antagonism is responsible for its |
Since agrin fragments induce | acetylcholine receptor aggregation as well as phosphoryl |
The muscle | acetylcholine receptor is composed of five subunits: two |
-246,708; Lumeron, Memcor) is a muscarinic | acetylcholine receptor agonist with reasonable selectivi |
amine acts in vitro as a strong muscarinic | acetylcholine receptor antagonist (anticholinergic) and |
e (WAL-2014) is a non-selective muscarinic | acetylcholine receptor agonist which acts as a full agon |
d that development of new neural nicotinic | acetylcholine receptor agonists will be likely to lead t |
as selective potentiator of α4β2 nicotinic | acetylcholine receptor responses by using two-electrode |
allosteric modulator of neuronal nicotinic | acetylcholine receptor with sub-type specificity for het |
d-gated ion channels such as the nicotinic | acetylcholine receptor and GABAA receptor are composed o |
ses the actions of the vagus nerve, blocks | acetylcholine receptor sites, and decreases bronchial se |
n, adrenenaline, histamine, and muscarinic | acetylcholine receptor antagonist, though with weaker an |
cking drugs in a long lineage of nicotinic | acetylcholine receptor anatagonists synthesized by Mary |
The | Acetylcholine receptor Pathways |
enacin works by blocking the M3 muscarinic | acetylcholine receptor, which is primarily responsible f |
nicotinic receptor is a type of nicotinic | acetylcholine receptor, consisting of the subunit combin |
nicotinic receptor is a type of nicotinic | acetylcholine receptor, consisting of the subunit combin |
the α3β4 receptor, is a type of nicotinic | acetylcholine receptor, consisting of α3 and β4 subunits |
This gene encodes the beta subunit of the | acetylcholine receptor. |
osely related by homology to the nicotinic | acetylcholine receptor. |
, nicotine acts primarily on the nicotinic | acetylcholine receptor. |
for the α2β2 subtype of neuronal nicotinic | acetylcholine receptor. |
ect causes "fast channel" behaviour of the | acetylcholine receptor. |
nicotinic | acetylcholine receptors (nAChR, also known as "ionotropi |
muscarinic | acetylcholine receptors (mAChR, also known as "metabotro |
cts of GHB are mediated through muscarinic | acetylcholine receptors and can be prevented by prior ad |
α-Bungarotoxin blocks nicotinic | acetylcholine receptors and has been used to isolate and |
d on its involvement in the aggregation of | acetylcholine receptors during synaptogenesis. |
Muscarinic | acetylcholine receptors belong to a class of metabotropi |
function of its competitive antagonism to | acetylcholine receptors of the nicotinic type. |
inhibition of both α2β2 and α4β2 Nicotinic | Acetylcholine Receptors by β-Amyloid (1-42) Peptide . |
nergic medication that inhibits muscarinic | acetylcholine receptors and thus the parasympathetic ner |
ich acts as an agonist at neural nicotinic | acetylcholine receptors with high selectivity for the α4 |
The nicotinic | acetylcholine receptors (nAChRs) are members of a superf |
hermore selective block of α9α10 nicotinic | acetylcholine receptors by the conotoxin RgIA has been s |
ceptors with similar potency and nicotinic | acetylcholine receptors to a much lesser extent. |
hycanthone binds to | acetylcholine receptors in the worm and result inincreas |
arch to map the distribution of muscarinic | acetylcholine receptors in the brain. |
n identified as an antagonist of nicotinic | acetylcholine receptors (nAChrs) in the muscle and brain |
as a mixed agonist-antagonist at nicotinic | acetylcholine receptors and an antagonist at μ-opioid re |
the H1 receptor (24,000 nM) or muscarinic | acetylcholine receptors (11,000 nM), and accordingly lac |
nM) > H1 receptor (3,100 nM) > muscarinic | acetylcholine receptors (>35,000). |
Selective block of α9α10 nicotinic | acetylcholine receptors by the conotoxin RgIA has been s |
ts on serotonin, histamine, and muscarinic | acetylcholine receptors have not been assayed, but uniqu |
does not have any effect on the muscarinic | acetylcholine receptors (mAChR) located on target organs |
ich acts as an agonist at neural nicotinic | acetylcholine receptors selective for the α4β2 subtype, |
and 18-methoxycoronaridine block nicotinic | acetylcholine receptors in the brain and can be used for |
that also includes the neuronal nicotinic | acetylcholine receptors (nAChRs), and the inhibitory neu |
ich acts as an agonist at neural nicotinic | acetylcholine receptors and has been researched for use |
arch to map the distribution of muscarinic | acetylcholine receptors in the brain, however this drug |
Main article: Muscarinic | acetylcholine receptors |
ct of the poisoning by blocking muscarinic | acetylcholine receptors, which would otherwise be overst |
vates, and desensitizes neuronal nicotinic | acetylcholine receptors, though at much lower potency in |
when the body produces antibodies against | acetylcholine receptors, and thus inhibits signal transm |
s as a partial agonist at neural nicotinic | acetylcholine receptors, binding to both the α3β4 and th |
ohol because alcohol potentiates nicotinic | acetylcholine receptors, leading to re-sensitization and |
ist for the α7 subtype of neural nicotinic | acetylcholine receptors, with a high level of brain pene |
as a partial agonist at neuronal nicotinic | acetylcholine receptors, binding to both the α3β4 and th |
receptors, opioid receptors, and nicotinic | acetylcholine receptors, but not benzodiazepinergic or m |
n including antagonist action at nicotinic | acetylcholine receptors, and it has also been shown to r |
receptors, histamine receptors, muscarinic | acetylcholine receptors, and serotonin receptors. |
potent and selective agonist for nicotinic | acetylcholine receptors, with twice the potency of nicot |
e partial agonist at α4β2 neural nicotinic | acetylcholine receptors, acting as an agonist at (α4)2(β |
s a mixed agonist-antagonist at muscarinic | acetylcholine receptors, being a potent and selective ag |
rgic that inhibits the action at nicotinic | acetylcholine receptors. |
y through dopamine modulation by nicotinic | acetylcholine receptors. |
t's nervous system by inhibiting nicotinic | acetylcholine receptors. |
er, α2-adrenergic receptor, and muscarinic | acetylcholine receptors. |
s as a partial agonist at neural nicotinic | acetylcholine receptors. |
for the D2, 5-HT2, H1, H2, and muscarinic | acetylcholine receptors. |
s as a partial agonist at neural nicotinic | acetylcholine receptors. |
ist for the α7 subtype of neural nicotinic | acetylcholine receptors. |
ist for the α7 subtype of neural nicotinic | acetylcholine receptors. |
ist for the α7 subtype of neural nicotinic | acetylcholine receptors. |
ist for the α7 subtype of neural nicotinic | acetylcholine receptors. |
lated by nicotinic ligand-gated ionotropic | acetylcholine receptors. |
eceptors, without affecting the muscarinic | acetylcholine receptors. |
amine receptors, as well as the muscarinic | acetylcholine receptors. |
as an antagonist towards various nicotinic | acetylcholine receptors. |
ny of the TCAs analyzed for the muscarinic | acetylcholine receptors. |
is of a radiotracer for studying nicotinic | acetylcholine receptors: (+/-)-Exo-2-(2-[F-18]fluoro-5-p |
It enhances | acetylcholine release through indirect activation of the |
ins depolarized and unresponsive to normal | acetylcholine release. |
elease, as well as modulating dopamine and | acetylcholine release. |
Similarly, | acetylcholine released from parasympathetic neurons may |
It hydrolyzes | acetylcholine to choline and an acetate group. |
he NMJ nAChRs by preventing the binding of | acetylcholine to its receptor. |
Binding of | acetylcholine to the N termini of each of the two alpha |
ry neurotransmitters such as glutamate and | acetylcholine via stimulation of H1 receptors in the cer |
stimulation, these nerve branches release | acetylcholine, which, in turn causes release of nitric o |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |
こんにちは ゲスト さん
ログイン |
Weblio会員(無料)になると 検索履歴を保存できる! 語彙力診断の実施回数増加! |